![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Guilford Publications Inc
ISSN: 1085-0295
Source: Child and Adolescent Psychopharmacology News, Vol.6, Iss.3, 2001-06, pp. : 1-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antidepressants and neuroleptic malignant syndrome
By Assion H.J. Heinemann F. Laux G.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacogenetic Aspects of Neuroleptic Malignant Syndrome
Current Pharmacogenomics, Vol. 4, Iss. 2, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Mild neuroleptic malignant syndrome: problems of differential diagnosis
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Aripiprazole: Neuroleptic malignant syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1124, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Paliperidone: Neuroleptic malignant syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1185, 2008-01 ,pp. :